Dispatches from the FT Global Healthcare and biotech conference
Small and Mid-sized pharma
“In this customer segment we can see the clear trend to completely exit their own manufacturing and rely on strong CDMOs. For them the optimisation is the cash situation meaning stronger focusing on core strategies are the key driver for outsourcing activities. This background also explains the increasing efforts to outsource the product”